Last reviewed · How we verify

A Pilot Study to Assess the Feasibility of a Future Randomized, Double-Blinded, Placebo-Controlled Trial to Investigate the Role of Intra-Peritoneal Ropivacaine in Gastric Bypass Surgery: INOPAIN Trial

NCT02154763 Phase 3 COMPLETED Results posted

This is a pilot study in a randomized, controlled, double-blinded format and will evaluate the ability of a local anesthetic, Ropivacaine, to decrease pain after gastric bypass surgery. The drug will be administered into the abdomen during a bariatric bypass surgery. After surgery, patients who received Ropivacaine will be compared to those without Ropivacaine to determine its effect on reducing pain, recovery of lung function, ability to walk, and quality of life during recovery.

Details

Lead sponsorOttawa Hospital Research Institute
PhasePhase 3
StatusCOMPLETED
Enrolment120
Start date2014-07
Completion2015-07

Conditions

Interventions

Primary outcomes

Countries

Canada